These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 35741861)

  • 1. Psychosis in Parkinson's Disease: A Lesson from Genetics.
    Angelopoulou E; Bougea A; Papageorgiou SG; Villa C
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson's disease psychosis.
    Kulick CV; Montgomery KM; Nirenberg MJ
    Parkinsonism Relat Disord; 2018 Sep; 54():40-45. PubMed ID: 29653909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosis in Parkinson's Disease: Looking Beyond Dopaminergic Treatments.
    Rojas M; Chávez-Castillo M; Duran P; Ortega Á; Bautista-Sandoval MJ; Salazar J; Riaño-Garzón M; Chacín M; Medina-Ortiz O; Palmar J; Cudris-Torres L; Bermúdez V
    Curr Pharm Des; 2022; 28(33):2725-2741. PubMed ID: 36321314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease psychosis: presentation, diagnosis and management.
    Schneider RB; Iourinets J; Richard IH
    Neurodegener Dis Manag; 2017 Dec; 7(6):365-376. PubMed ID: 29160144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hallucinations and delusions associated with Parkinson's disease psychosis: safety of current treatments and future directions.
    Isaacson SH; Citrome L
    Expert Opin Drug Saf; 2022 Jul; 21(7):873-879. PubMed ID: 35466847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of psychosis in Parkinson's disease.
    Fénelon G; Alves G
    J Neurol Sci; 2010 Feb; 289(1-2):12-7. PubMed ID: 19740486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms.
    Lee AH; Weintraub D
    Mov Disord; 2012 Jun; 27(7):858-63. PubMed ID: 22674352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.
    Ffytche DH; Pereira JB; Ballard C; Chaudhuri KR; Weintraub D; Aarsland D
    J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):325-331. PubMed ID: 28315846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosis in Parkinson's Disease: Current Treatment Options and Impact on Patients and Caregivers.
    Segal GS; Xie SJ; Paracha SU; Grossberg GT
    J Geriatr Psychiatry Neurol; 2021 Jul; 34(4):274-279. PubMed ID: 34219522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic substrates of psychosis in patients with Parkinson's disease: A critical review.
    Lenka A; Arumugham SS; Christopher R; Pal PK
    J Neurol Sci; 2016 May; 364():33-41. PubMed ID: 27084212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parkinson's disease and psychoses].
    Bizzarri JV; Giupponi G; Maniscalco I; Schroffenegger P; Conca A; Kapfhammer HP
    Neuropsychiatr; 2015; 29(1):1-13. PubMed ID: 25586068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deconstructing psychosis and misperception symptoms in Parkinson's disease.
    Nishio Y; Yokoi K; Uchiyama M; Mamiya Y; Watanabe H; Gang M; Baba T; Takeda A; Hirayama K; Mori E
    J Neurol Neurosurg Psychiatry; 2017 Sep; 88(9):722-729. PubMed ID: 28600444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms.
    Fénelon G
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):18-25. PubMed ID: 18323763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening, Diagnosis, and Management of Parkinson's Disease Psychosis: Recommendations From an Expert Panel.
    Pahwa R; Isaacson SH; Small GW; Torres-Yaghi Y; Pagan F; Sabbagh M
    Neurol Ther; 2022 Dec; 11(4):1571-1582. PubMed ID: 35906500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosis in Parkinson's disease.
    Thanvi BR; Lo TC; Harsh DP
    Postgrad Med J; 2005 Oct; 81(960):644-6. PubMed ID: 16210460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease psychosis: symptoms, management, and economic burden.
    Hermanowicz N; Edwards K
    Am J Manag Care; 2015 Aug; 21(10 Suppl):s199-206. PubMed ID: 26296199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does an association between cigarette smoking and Parkinson's Disease-related psychosis exist? Insights from a large non-demented cohort.
    Terravecchia C; Mostile G; Rascunà C; Arabia G; Barone P; Marconi R; Morgante L; Quattrone A; Nicoletti A; Zappia M
    J Neurol Sci; 2021 Aug; 427():117509. PubMed ID: 34082149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective study.
    Yuan M; Sperry L; Malhado-Chang N; Duffy A; Wheelock V; Farias S; O'Connor K; Olichney J; Shahlaie K; Zhang L
    Brain Behav; 2017 Jun; 7(6):e00639. PubMed ID: 28638698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease and Parkinson's disease psychosis: a perspective on the challenges, treatments, and economic burden.
    Fredericks D; Norton JC; Atchison C; Schoenhaus R; Pill MW
    Am J Manag Care; 2017 Apr; 23(5 Suppl):S83-S92. PubMed ID: 28715903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology and treatment of psychosis in Parkinson's disease: a review.
    Zahodne LB; Fernandez HH
    Drugs Aging; 2008; 25(8):665-82. PubMed ID: 18665659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.